Purification of human renin substrate.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Analytical Biochemistry

• Publication date

  1978-06-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0003-2697(78)90563-8PMID 27994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple forms of renin substrate in human plasma.

  1978cited by this paper
• Human angiotensinogen. Purification partial characterization, and a comparison with animal prohormones.

  1977cited by this paper
• Partial Purification of Human Renin Substrate

  1976cited by this paper
• The biochemistry of the renin-angiotensin system and its role in hypertension.

  1976cited by this paper
• Isolation of human angiotensinogen.

  1976cited by this paper
• Purification and partial characterization of human angiotensinogen.

  1976cited by this paper
• Purification, properties and kinetics of sheep and human renin substrates.

  1975cited by this paper
• Preparation of human angiotensinogen for plasma renin concentration assay.

  1974cited by this paper
• Enzyme kinetic studies on human renin and its purified homologous substrate.

  1971cited by this paper
• Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

  1969cited by this paper
• The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

  1965cited by this paper
• DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS *

  1964cited by this paper
• THE PURIFICATION AND PARTIAL CHARACTERIZATION OF SEVERAL FORMS OF HOG RENIN SUBSTRATE

  1963cited by this paper
• A method of assaying small amounts of hypertensin.

  1953cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Assessment of the Therapeutic Potential of Hesperidin and Quercetin Nanoparticles on Oxidative Stress, Enzyme Activities, Trophic Factors, and Monoamines in an Animal Model of Depression

  2025cites this paper
• Taurine protection attenuates bisphenol-A-induced behavioral, neurochemical, and histopathological alterations in male rats

  2025cites this paper
• Renin inhibitors.

  1991cites this paper
• Novel inhibitors of human renin. Cyclic peptides based on the tetrapeptide sequence Glu-D-Phe-Lys-D-Trp.

  1990cites this paper
• 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives.

  1990cites this paper
• Pure human inactive renin. Evidence that native inactive renin is prorenin.

  1989cites this paper
• Azido glycols: potent, low molecular weight renin inhibitors containing an unusual post scissile site residue.

  1989cites this paper
• Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.

  1988cites this paper
• Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.

  1988cites this paper
• Renin inhibitors Improvements in the stability and biological activity of small peptides containing novel Leu‐Val replacements

  1988cites this paper
• Human placental chorionic renin: production, purification and characterization.

  1988cites this paper
• New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.

  1988cites this paper
• Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.

  1987cites this paper
• Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.

  1987cites this paper
• Angiotensinogen is an acute-phase protein in man.

  1987cites this paper
• New inhibitors of human renin that contain novel Leu-Val replacements.

  1987cites this paper
• Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement.

  1987cites this paper
• Modified peptides which display potent and specific inhibition of human renin.

  1987cites this paper
• Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.

  1987cites this paper
• Highly potent and specific inhibitors of human renin

  1987cites this paper
• Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition.

  1986cites this paper
• Purification of rat angiotensinogen.

  1986cites this paper
• Purification and characterization of ovine angiotensinogen.

  1986cites this paper
• Characterization of precursor and secreted forms of human angiotensinogen.

  1985cites this paper
• Studies on the Purification and Characterization of Human Angiotensinogen

  1984cites this paper
• Characterization of precursor and secreted forms of rat angiotensinogen.

  1984cites this paper
• Structural aspects of rat angiotensinogen.

  1983cites this paper
• ROLE OF CELL SURFACE COMPONENTS AND RECEPTORS IN THROMBIN-STIMULATED CELL DIVISION1

  1982cites this paper
• Separation and characterization of two different species of rat angiotensinogen.

  1982cites this paper
• Formation of angiotensin II by tonin from partially purified human angiotensinogen.

  1981cites this paper
• Pure human renin. Identification and characterization and of two major molecular weight forms.

  1981cites this paper
• Rat angiotensinogen and des(angiotensin I)angiotensinogen: purification, characterization, and partial sequencing.

  1981cites this paper
• The biochemistry of the renin-angiotensin system.

  1980cites this paper
• Isolation and characterization of human renin substrate.

  1980cites this paper
• Purification and characterization of rat angiotensinogen.

  1979cites this paper
• Human plasma angiotensinogen: A review of purification procedures

  1979cites this paper